GOLIMUMAB

GOLIMUMAB was reported 12593 times

GOLIMUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5486 0.7649
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 493 0.7380
2 SWOLLEN JOINT COUNT INCREASED 2267 0.7102
3 RHEUMATIC FEVER 3081 0.6905
4 PEMPHIGUS 8418 0.6726
5 RHEUMATOID FACTOR POSITIVE 3842 0.6645
6 HEPATIC ENZYME 99 0.6644
7 LUPUS VULGARIS 789 0.6262
8 DUODENAL ULCER PERFORATION 4532 0.6088
9 DEEP VEIN THROMBOSIS POSTOPERATIVE 1217 0.6076
10 RED BLOOD CELL SEDIMENTATION RATE 157 0.5627
11 C-REACTIVE PROTEIN 520 0.5609
12 HAND DEFORMITY 7241 0.5515
13 SWOLLEN JOINT COUNT 134 0.5360
14 MALIGNANT MEDIASTINAL NEOPLASM 57 0.5182
15 FACET JOINT SYNDROME 1670 0.5124
16 GRIP STRENGTH 115 0.5022
17 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1013 0.4884
18 MUSCLE INJURY 3911 0.4715
19 HELICOBACTER INFECTION 4685 0.4554
20 DISLOCATION OF VERTEBRA 1028 0.4503
21 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2918 0.4489
22 X-RAY ABNORMAL 779 0.4352
23 SYNOVIAL FLUID ANALYSIS 37 0.4253
24 FOLLICULITIS 4397 0.4189
25 SYNOVITIS 7511 0.4161
26 C-REACTIVE PROTEIN ABNORMAL 2488 0.3875
27 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 215 0.3832
28 RETINITIS 653 0.3777
29 GLOSSODYNIA 8276 0.3693
30 SERONEGATIVE ARTHRITIS 415 0.3621
31 GRANULOMA SKIN 288 0.3508
32 PERICARDITIS 5884 0.3499
33 HYPOCHOLESTEROLAEMIA 119 0.3371
34 PERIPHERAL VENOUS DISEASE 1365 0.3339
35 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 33 0.3143
36 BONE EROSION 1092 0.3085
37 ANKLE ARTHROPLASTY 103 0.2837
38 CONTRAINDICATED PRODUCT ADMINISTERED 8535 0.2816
39 WOUND 7014 0.2507
40 DRUG TOLERANCE DECREASED 694 0.2469
41 SYSTEMIC LUPUS ERYTHEMATOSUS 8679 0.2443
42 ANTICIPATORY ANXIETY 60 0.2206
43 ENTHESOPATHY 333 0.2128
44 BLOOD PARATHYROID HORMONE DECREASED 312 0.2104
45 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 483 0.2095
46 IRRITABLE BOWEL SYNDROME 4436 0.2067
47 BREAST CANCER STAGE III 1328 0.2048
48 ONYCHOMADESIS 860 0.2047
49 GRIP STRENGTH DECREASED 1727 0.1960
50 PORPHYRIA ACUTE 268 0.1868
51 LIP DRY 1687 0.1855
52 RHEUMATOID NODULE 505 0.1832
53 OVERLAP SYNDROME 127 0.1814
54 HYPERCHOLESTEROLAEMIA 1689 0.1748
55 ONYCHOMYCOSIS 753 0.1714
56 JOINT RANGE OF MOTION DECREASED 2226 0.1658
57 NAIL OPERATION 68 0.1643
58 WOUND INFECTION 1677 0.1530
59 JOINT DESTRUCTION 229 0.1472
60 DEVICE DEPLOYMENT ISSUE 1858 0.1453
61 LOWER RESPIRATORY TRACT INFECTION 6558 0.1441
62 BURSITIS 1745 0.1437
63 ARTHROPATHY 7897 0.1419
64 THERAPEUTIC PRODUCT EFFECT DECREASED 6335 0.1413
65 IMPAIRED HEALING 4588 0.1396
66 PANNICULITIS 337 0.1391
67 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1532 0.1383
68 LIVE BIRTH 1145 0.1367
69 FIBROMYALGIA 3283 0.1349
70 PSORIATIC ARTHROPATHY 5481 0.1349
71 TENOSYNOVITIS 371 0.1344
72 MUSCULOSKELETAL DEFORMITY 31 0.1325
73 RHEUMATOID ARTHRITIS 14580 0.1283
74 AUTOIMMUNE DISORDER 1209 0.1239
75 BLEPHAROSPASM 780 0.1238
76 NAIL DISORDER 1065 0.1216
77 LIVER INJURY 2925 0.1190
78 HYPERMOBILITY SYNDROME 58 0.1165
79 DEATH NEONATAL 158 0.1135
80 TENOSYNOVITIS STENOSANS 61 0.1095
81 BUNION OPERATION 61 0.1087
82 SCIATICA 1719 0.1077
83 BLOOD IRON ABNORMAL 105 0.1075
84 FOOT DEFORMITY 1186 0.1069
85 HIP ARTHROPLASTY 1637 0.1068
86 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 85 0.1065
87 ARTHRODESIS 108 0.1061
88 JOINT ANKYLOSIS 60 0.1056
89 FINGER DEFORMITY 510 0.1052
90 TYPE 2 DIABETES MELLITUS 3536 0.1049
91 EXOSTOSIS 923 0.1010
92 INFUSION RELATED REACTION 6606 0.0996
93 PUSTULAR PSORIASIS 333 0.0969
94 DISCOMFORT 5779 0.0946
95 DRUG INTOLERANCE 9064 0.0937
96 SWELLING 8755 0.0935
97 OBESITY 1466 0.0919
98 RHEUMATOID LUNG 87 0.0911
99 PULMONARY FIBROSIS 1741 0.0907
100 HEPATIC ENZYME INCREASED 6180 0.0906
101 MATERNAL EXPOSURE TIMING UNSPECIFIED 337 0.0896
102 ALANINE AMINOTRANSFERASE ABNORMAL 185 0.0876
103 ANKYLOSING SPONDYLITIS 1149 0.0871
104 WALKING AID USER 564 0.0855
105 KNEE ARTHROPLASTY 1792 0.0850
106 BLISTER 4683 0.0833
107 JOINT SWELLING 10050 0.0832
108 PRODUCT LABEL CONFUSION 479 0.0821
109 TREATMENT FAILURE 6775 0.0817
110 LUPUS-LIKE SYNDROME 740 0.0815
111 DRUG DELIVERY SYSTEM MALFUNCTION 413 0.0807
112 DRUG TOLERANCE 403 0.0796
113 DENGUE FEVER 178 0.0775
114 NECK DEFORMITY 34 0.0766
115 EXTREMITY CONTRACTURE 49 0.0766
116 LOWER LIMB FRACTURE 1459 0.0759
117 SYNOVIAL DISORDER 34 0.0747
118 CHIKUNGUNYA VIRUS INFECTION 41 0.0733
119 PEPTIC ULCER HAEMORRHAGE 51 0.0732
120 JOINT DISLOCATION 772 0.0730
121 BACK INJURY 790 0.0726
122 STOMATITIS 4375 0.0721
123 BLOOD CHOLESTEROL INCREASED 3353 0.0719
124 MYCOTIC ALLERGY 61 0.0713
125 COELIAC DISEASE 696 0.0709
126 AXIAL SPONDYLOARTHRITIS 62 0.0705
127 SPONDYLITIS 252 0.0692
128 PRESCRIBED OVERDOSE 1329 0.0686
129 INFUSION SITE REACTION 204 0.0682
130 NIGHT SWEATS 2194 0.0680
131 BLOOD FOLATE DECREASED 48 0.0660
132 GAIT INABILITY 2185 0.0653
133 C-REACTIVE PROTEIN DECREASED 42 0.0643
134 C-REACTIVE PROTEIN INCREASED 2339 0.0642
135 ILL-DEFINED DISORDER 3754 0.0617
136 MATERNAL EXPOSURE DURING PREGNANCY 5503 0.0617
137 OSTEOARTHRITIS 2614 0.0616
138 WRIST DEFORMITY 37 0.0602
139 SKIN NECROSIS 311 0.0599
140 MUSCULOSKELETAL STIFFNESS 5221 0.0595
141 INFLAMMATION 2988 0.0578
142 CONGENITAL ANOMALY 444 0.0573
143 PRESCRIBED UNDERDOSE 1143 0.0572
144 MOBILITY DECREASED 4041 0.0562
145 BREAST CANCER STAGE II 466 0.0560
146 ULCER HAEMORRHAGE 378 0.0558
147 TOE OPERATION 43 0.0547
148 MUSCLE SPASTICITY 658 0.0535
149 ABDOMINAL DISCOMFORT 8958 0.0534
150 POLYARTHRITIS 278 0.0527
151 LIVER FUNCTION TEST INCREASED 1128 0.0525
152 EYE INJURY 159 0.0523
153 SPONDYLOARTHROPATHY 31 0.0517
154 EAR PAIN 1001 0.0514
155 SINUSITIS 5265 0.0513
156 ADMINISTRATION SITE PAIN 59 0.0512
157 SKIN NEOPLASM EXCISION 40 0.0511
158 LARYNGEAL DISORDER 36 0.0499
159 ALOPECIA 9547 0.0486
160 VASCULAR ACCESS COMPLICATION 38 0.0469
161 JOINT STIFFNESS 1215 0.0463
162 SCLERITIS 74 0.0462
163 RASH VESICULAR 221 0.0457
164 GASTROINTESTINAL DISORDER 4090 0.0456
165 HEPATIC CIRRHOSIS 851 0.0452
166 DACTYLITIS 44 0.0448
167 DEVICE DEFECTIVE 771 0.0444
168 INJURY 3111 0.0442
169 INFLAMMATORY PAIN 30 0.0442
170 SACROILIITIS 83 0.0439
171 INFECTION 6346 0.0438
172 INTERVERTEBRAL DISC SPACE NARROWING 35 0.0434
173 SPINAL FUSION SURGERY 176 0.0433
174 BONE CYST 40 0.0426
175 WHEEZING 2529 0.0426
176 MUSCULOSKELETAL PAIN 2224 0.0424
177 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2020 0.0420
178 HYPERSENSITIVITY 7749 0.0417
179 JUVENILE IDIOPATHIC ARTHRITIS 102 0.0417
180 FOOT OPERATION 206 0.0416
181 NEEDLE ISSUE 1193 0.0409
182 RHEUMATIC DISORDER 79 0.0408
183 PERIPHERAL SWELLING 6224 0.0404
184 ALLERGY TO CHEMICALS 50 0.0401
185 NEOPLASM SKIN 62 0.0399
186 FINE MOTOR SKILL DYSFUNCTION 115 0.0397
187 GENERAL PHYSICAL HEALTH DETERIORATION 4548 0.0393
188 SLEEP DISORDER 2753 0.0390
189 LATENT TUBERCULOSIS 81 0.0386
190 TASTE DISORDER 781 0.0385
191 DEVICE FAILURE 571 0.0375
192 UVEITIS 504 0.0371
193 NORMAL NEWBORN 201 0.0369
194 ROAD TRAFFIC ACCIDENT 1537 0.0367
195 LUNG DISORDER 1781 0.0363
196 JOINT ARTHROPLASTY 65 0.0363
197 EXPOSURE DURING PREGNANCY 2251 0.0362
198 OEDEMA 1964 0.0362
199 THERAPY NON-RESPONDER 1625 0.0361
200 LIVER DISORDER 1598 0.0360
201 LIP ULCERATION 42 0.0359
202 INTENTIONAL PRODUCT USE ISSUE 3127 0.0357
203 DEVICE MALFUNCTION 2499 0.0355
204 ADVERSE REACTION 471 0.0355
205 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 595 0.0347
206 INTERVERTEBRAL DISC COMPRESSION 36 0.0345
207 CONTUSION 3320 0.0345
208 RESPIRATORY DISORDER 1025 0.0342
209 BODY TEMPERATURE INCREASED 695 0.0340
210 TONGUE DISORDER 246 0.0340
211 PRODUCT USE ISSUE 6332 0.0337
212 PULMONARY TUBERCULOSIS 142 0.0332
213 BASAL CELL CARCINOMA 515 0.0330
214 TONSILLITIS 170 0.0325
215 METABOLIC SURGERY 37 0.0325
216 DRUG-INDUCED LIVER INJURY 1012 0.0322
217 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2290 0.0322
218 EAR INFECTION 852 0.0320
219 PREGNANCY 640 0.0319
220 BONE SWELLING 30 0.0310
221 ARTHRITIS BACTERIAL 127 0.0309
222 SERUM FERRITIN DECREASED 53 0.0307
223 NASOPHARYNGITIS 5638 0.0306
224 INCORRECT PRODUCT STORAGE 401 0.0305
225 DELIRIUM 1025 0.0295
226 INFECTED CYST 35 0.0292
227 LOWER RESPIRATORY TRACT CONGESTION 49 0.0288
228 RHEUMATOID FACTOR INCREASED 32 0.0286
229 DISABILITY 563 0.0284
230 POST PROCEDURAL INFECTION 231 0.0284
231 GENERAL SYMPTOM 210 0.0280
232 ARTHRITIS 2191 0.0278
233 JOINT EFFUSION 191 0.0277
234 ARTHRITIS INFECTIVE 127 0.0274
235 HEPATITIS 693 0.0271
236 DEVICE ISSUE 2426 0.0270
237 MYOSITIS 241 0.0268
238 TOOTH ABSCESS 271 0.0266
239 NODULE 347 0.0266
240 OSTEOPOROSIS 1089 0.0264
241 LIMB DEFORMITY 42 0.0264
242 EPILEPSY 804 0.0263
243 COLITIS ULCERATIVE 1175 0.0263
244 TERMINAL INSOMNIA 46 0.0260
245 CONFUSIONAL STATE 4170 0.0258
246 HYPERCALCAEMIA 318 0.0257
247 DRUG SPECIFIC ANTIBODY 35 0.0255
248 PHARYNGITIS 316 0.0254
249 ULCER 404 0.0254
250 KIDNEY INFECTION 489 0.0249
251 SHOULDER ARTHROPLASTY 67 0.0249
252 DRY MOUTH 2005 0.0247
253 DEFORMITY 230 0.0246
254 SPINAL STENOSIS 101 0.0244
255 ARTHRALGIA 10043 0.0241
256 ATYPICAL MYCOBACTERIAL INFECTION 34 0.0240
257 NECK PAIN 1340 0.0240
258 THERAPEUTIC RESPONSE DECREASED 1439 0.0237
259 BLOOD IMMUNOGLOBULIN E INCREASED 57 0.0235
260 IMMOBILE 102 0.0233
261 PULMONARY TOXICITY 164 0.0232
262 ERYSIPELAS 116 0.0231
263 DERMATITIS PSORIASIFORM 47 0.0230
264 SYNOVIAL CYST 106 0.0229
265 PYELONEPHRITIS ACUTE 45 0.0229
266 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 56 0.0226
267 VASCULAR RUPTURE 35 0.0226
268 PAIN 13807 0.0225
269 ANAL ABSCESS 121 0.0224
270 URTICARIA 3737 0.0223
271 RASH 9695 0.0222
272 DECREASED IMMUNE RESPONSIVENESS 217 0.0221
273 GASTROINTESTINAL TOXICITY 106 0.0220
274 BEDRIDDEN 288 0.0219
275 ADVERSE EVENT 2017 0.0219
276 WEIGHT INCREASED 4833 0.0216
277 HYPOAESTHESIA 3220 0.0215
278 LYMPHOPROLIFERATIVE DISORDER 63 0.0214
279 PNEUMONIA LEGIONELLA 34 0.0212
280 COLECTOMY 120 0.0212
281 EFFUSION 29 0.0212
282 CONDITION AGGRAVATED 6424 0.0211
283 BREATH SOUNDS ABNORMAL 104 0.0211
284 HYPERTENSION 4429 0.0209
285 INVESTIGATION ABNORMAL 30 0.0209
286 GASTROINTESTINAL INFECTION 187 0.0208
287 HERPES VIRUS INFECTION 120 0.0208
288 VAGINAL INFECTION 98 0.0208
289 GRANULOMA 72 0.0208
290 PYELONEPHRITIS 180 0.0208
291 MEAN CELL VOLUME DECREASED 32 0.0207
292 NASAL ULCER 33 0.0207
293 TOOTH INFECTION 273 0.0207
294 NERVE INJURY 228 0.0205
295 TENDONITIS 317 0.0205
296 INFLAMMATORY MARKER INCREASED 101 0.0204
297 JOINT INJURY 431 0.0202
298 DRUG USE DISORDER 169 0.0201
299 DRUG ERUPTION 350 0.0197
300 DYSPEPSIA 1932 0.0196
301 SKIN ULCER 507 0.0196
302 DRUG SPECIFIC ANTIBODY PRESENT 127 0.0195
303 INJECTION RELATED REACTION 32 0.0194
304 IRIDOCYCLITIS 61 0.0193
305 LYME DISEASE 64 0.0192
306 NECK MASS 54 0.0191
307 PNEUMONIA 6139 0.0189
308 POSTOPERATIVE WOUND INFECTION 128 0.0189
309 DIVERTICULAR PERFORATION 39 0.0189
310 DIVERTICULITIS 525 0.0189
311 VARICELLA 45 0.0188
312 MIGRAINE 1786 0.0187
313 MEAN CELL HAEMOGLOBIN DECREASED 34 0.0186
314 INFECTED SKIN ULCER 35 0.0185
315 HYSTERECTOMY 160 0.0185
316 IRITIS 56 0.0184
317 PRODUCT CONTAINER SEAL ISSUE 32 0.0184
318 PRODUCT LEAKAGE 103 0.0183
319 VIRAL UPPER RESPIRATORY TRACT INFECTION 87 0.0183
320 OSTEOMYELITIS 330 0.0182
321 ADVERSE DRUG REACTION 1632 0.0182
322 PRODUCT DOSE OMISSION ISSUE 5329 0.0181
323 ANTINUCLEAR ANTIBODY POSITIVE 58 0.0178
324 CREPITATIONS 53 0.0178
325 OSTEOLYSIS 36 0.0176
326 DISSEMINATED TUBERCULOSIS 45 0.0175
327 SYRINGE ISSUE 306 0.0175
328 BONE LESION 63 0.0175
329 FREQUENT BOWEL MOVEMENTS 471 0.0174
330 UNDERDOSE 1268 0.0174
331 UPPER RESPIRATORY TRACT INFECTION 802 0.0173
332 MULTIPLE ALLERGIES 136 0.0173
333 ACCIDENTAL EXPOSURE TO PRODUCT 1787 0.0173
334 DEMYELINATION 71 0.0173
335 DRUG DOSE OMISSION 2861 0.0173
336 FEAR OF INJECTION 123 0.0172
337 WHEELCHAIR USER 76 0.0171
338 MENOPAUSE 44 0.0171
339 PLEURITIC PAIN 47 0.0170
340 PULMONARY MASS 250 0.0168
341 IMMUNODEFICIENCY 250 0.0168
342 SUBCUTANEOUS ABSCESS 80 0.0167
343 ABSCESS LIMB 71 0.0166
344 SPINAL PAIN 195 0.0166
345 LIMB OPERATION 79 0.0165
346 ORAL DISCOMFORT 228 0.0164
347 DRUG INEFFECTIVE 21528 0.0163
348 RESPIRATORY TRACT INFECTION 423 0.0162
349 HEPATIC ENZYME ABNORMAL 81 0.0162
350 ADRENAL INSUFFICIENCY 197 0.0162
351 GASTRIC INFECTION 62 0.0162
352 AMNESIA 1035 0.0159
353 NOSOCOMIAL INFECTION 35 0.0159
354 MUSCULOSKELETAL DISORDER 301 0.0158
355 INJECTION SITE REACTION 1081 0.0157
356 THYROID NEOPLASM 43 0.0156
357 CUSHINGOID 50 0.0156
358 TENDERNESS 162 0.0155
359 ABDOMINAL PAIN UPPER 3195 0.0155
360 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 263 0.0155
361 CELLULITIS 780 0.0155
362 TUBERCULIN TEST POSITIVE 39 0.0154
363 CHEMOTHERAPY 58 0.0153
364 BRONCHIECTASIS 103 0.0153
365 BACK DISORDER 248 0.0152
366 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 36 0.0152
367 KERATITIS 46 0.0151
368 HEPATITIS B REACTIVATION 48 0.0151
369 INVASIVE DUCTAL BREAST CARCINOMA 41 0.0151
370 PULMONARY CONGESTION 198 0.0150
371 FATIGUE 11655 0.0150
372 ILEOSTOMY 38 0.0149
373 CHONDROPATHY 40 0.0148
374 HERPES ZOSTER 841 0.0146
375 ASTHMA 1637 0.0145
376 B-CELL LYMPHOMA 49 0.0144
377 BRONCHITIS 1065 0.0144
378 PNEUMONIA BACTERIAL 132 0.0144
379 MUSCULAR WEAKNESS 1634 0.0144
380 INFLUENZA 1598 0.0143
381 HEPATOTOXICITY 319 0.0143
382 LABYRINTHITIS 36 0.0142
383 WEIGHT FLUCTUATION 149 0.0142
384 SKIN INJURY 47 0.0142
385 DIARRHOEA HAEMORRHAGIC 132 0.0141
386 NEPHROLITHIASIS 645 0.0140
387 MEDICATION ERROR 772 0.0139
388 LOCALISED INFECTION 334 0.0138
389 PAIN IN EXTREMITY 4052 0.0137
390 MALIGNANT MELANOMA 184 0.0137
391 BODY TEMPERATURE DECREASED 135 0.0137
392 APPENDICITIS 128 0.0137
393 RHINITIS 110 0.0136
394 SKIN INFECTION 153 0.0136
395 KNEE OPERATION 134 0.0136
396 GASTROOESOPHAGEAL REFLUX DISEASE 1094 0.0136
397 ORAL INFECTION 53 0.0135
398 PYREXIA 4682 0.0135
399 DEVICE LEAKAGE 582 0.0134
400 FOOT FRACTURE 254 0.0134
401 PRURITUS 5130 0.0133
402 LUNG ADENOCARCINOMA 40 0.0133
403 INJURY ASSOCIATED WITH DEVICE 270 0.0132
404 INTERVERTEBRAL DISC DISORDER 56 0.0131
405 MEMORY IMPAIRMENT 1797 0.0131
406 LYMPHOMA 202 0.0131
407 CYTOMEGALOVIRUS COLITIS 30 0.0130
408 TONGUE ULCERATION 44 0.0130
409 INFLAMMATORY BOWEL DISEASE 127 0.0130
410 EYE INFECTION 146 0.0129
411 ORAL HERPES 252 0.0129
412 RESPIRATORY TRACT INFECTION VIRAL 30 0.0129
413 SHOULDER OPERATION 55 0.0129
414 CHRONIC GASTRITIS 29 0.0128
415 SUSPECTED OFF LABEL USE 58 0.0128
416 PRODUCT LABEL ISSUE 87 0.0128
417 DRUG EFFECT DECREASED 683 0.0127
418 INSOMNIA 3375 0.0127
419 RESPIRATORY TRACT CONGESTION 201 0.0126
420 PSORIASIS 1648 0.0126
421 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 29 0.0125
422 ULCERATIVE KERATITIS 34 0.0124
423 HEPATIC FIBROSIS 42 0.0122
424 GALLBLADDER OPERATION 49 0.0121
425 OFF LABEL USE 10538 0.0120
426 RASH PRURITIC 649 0.0120
427 SURGERY 702 0.0120
428 GAIT DISTURBANCE 2285 0.0119
429 PNEUMOCYSTIS JIROVECII PNEUMONIA 119 0.0118
430 CARPAL TUNNEL SYNDROME 165 0.0118
431 PARAESTHESIA 1851 0.0118
432 FURUNCLE 93 0.0117
433 PYODERMA GANGRENOSUM 42 0.0117
434 GASTROENTERITIS VIRAL 210 0.0116
435 LOSS OF THERAPEUTIC RESPONSE 37 0.0116
436 LIMB DISCOMFORT 356 0.0115
437 VASCULITIS 133 0.0114
438 GASTRIC DISORDER 391 0.0114
439 VIRAL INFECTION 376 0.0113
440 PNEUMONIA VIRAL 36 0.0113
441 PRODUCT DOSE OMISSION 737 0.0113
442 JOINT LOCK 32 0.0113
443 HIP SURGERY 61 0.0113
444 GASTROENTERITIS 163 0.0112
445 DECREASED APPETITE 2577 0.0111
446 ORAL CANDIDIASIS 145 0.0110
447 ANKLE FRACTURE 170 0.0110
448 LUMBAR SPINAL STENOSIS 32 0.0109
449 PRODUCT USE IN UNAPPROVED INDICATION 2706 0.0109
450 RECTAL HAEMORRHAGE 467 0.0109
451 SKIN CANCER 234 0.0109
452 ABDOMINAL ABSCESS 48 0.0108
453 CHEST PAIN 2007 0.0108
454 ABSCESS 172 0.0108
455 MOUTH ULCERATION 226 0.0107
456 MATERNAL EXPOSURE BEFORE PREGNANCY 73 0.0107
457 HAEMORRHAGIC DIATHESIS 38 0.0107
458 PRODUCT PACKAGING ISSUE 101 0.0106
459 NEOPLASM 121 0.0105
460 URINARY TRACT INFECTION 1794 0.0105
461 HYPERTRANSAMINASAEMIA 73 0.0105
462 PLANTAR FASCIITIS 35 0.0104
463 DERMATITIS ALLERGIC 130 0.0103
464 IMMUNE SYSTEM DISORDER 135 0.0102
465 MALAISE 4487 0.0102
466 HEADACHE 6412 0.0102
467 NEOPLASM MALIGNANT 682 0.0102
468 OEDEMA PERIPHERAL 1241 0.0102
469 CLOSTRIDIUM DIFFICILE INFECTION 222 0.0102
470 SPINAL DISORDER 96 0.0101
471 COLITIS MICROSCOPIC 48 0.0101
472 LUNG INFECTION 157 0.0101
473 RECTAL CANCER 31 0.0101
474 SPINAL OPERATION 124 0.0101
475 INTERVERTEBRAL DISC PROTRUSION 220 0.0101
476 OTITIS MEDIA 33 0.0100
477 CERVIX CARCINOMA 39 0.0100
478 SKIN REACTION 140 0.0099
479 VOMITING 4661 0.0099
480 COVID-19 PNEUMONIA 117 0.0099
481 GLAUCOMA 190 0.0099
482 CANDIDA INFECTION 166 0.0098
483 SQUAMOUS CELL CARCINOMA 92 0.0098
484 DRUG EFFECT INCOMPLETE 354 0.0097
485 DYSLIPIDAEMIA 49 0.0096
486 HEPATIC STEATOSIS 179 0.0096
487 CUTANEOUS VASCULITIS 35 0.0096
488 HERNIA 185 0.0096
489 MUSCLE SPASMS 1747 0.0095
490 ASPARTATE AMINOTRANSFERASE INCREASED 504 0.0095
491 ALANINE AMINOTRANSFERASE INCREASED 581 0.0095
492 GINGIVITIS 51 0.0094
493 CLAVICLE FRACTURE 36 0.0094
494 VISUAL IMPAIRMENT 1164 0.0094
495 PHLEBITIS 48 0.0094
496 LUNG NEOPLASM 40 0.0094
497 BONE DENSITY ABNORMAL 35 0.0094
498 ANAPHYLACTIC REACTION 513 0.0093
499 HAEMATOCHEZIA 510 0.0092
500 DEPRESSION 2081 0.0091
501 IMPAIRED WORK ABILITY 195 0.0091
502 GUILLAIN-BARRE SYNDROME 44 0.0091
503 ROTATOR CUFF SYNDROME 116 0.0090
504 FRACTURE 169 0.0089
505 PLEURISY 53 0.0089
506 FUNGAL SKIN INFECTION 36 0.0089
507 TRIGGER FINGER 36 0.0088
508 ENDOMETRIOSIS 42 0.0088
509 GOITRE 36 0.0088
510 ASTHENIA 3271 0.0087
511 ABDOMINAL PAIN 2020 0.0087
512 WOUND SECRETION 34 0.0087
513 SPINAL COLUMN STENOSIS 41 0.0087
514 EYE OPERATION 40 0.0087
515 URINARY TRACT DISORDER 39 0.0087
516 INTERSTITIAL LUNG DISEASE 419 0.0086
517 APPARENT DEATH 31 0.0086
518 DYSPNOEA 4860 0.0086
519 ERYTHEMA NODOSUM 30 0.0085
520 BACTERIAL INFECTION 159 0.0085
521 BLOOD PRESSURE SYSTOLIC INCREASED 166 0.0085
522 THYROID CANCER 102 0.0085
523 APPETITE DISORDER 56 0.0084
524 UROSEPSIS 77 0.0083
525 VARICOSE VEIN 43 0.0083
526 BACK PAIN 1925 0.0083
527 WHITE BLOOD CELL COUNT INCREASED 317 0.0083
528 DIARRHOEA 5315 0.0082
529 INTESTINAL RESECTION 44 0.0082
530 DEVICE MECHANICAL ISSUE 112 0.0082
531 APPENDICECTOMY 29 0.0081
532 TENDON DISORDER 53 0.0081
533 SKIN WARM 47 0.0081
534 THYROID DISORDER 124 0.0080
535 CYSTITIS 256 0.0080
536 ESCHERICHIA URINARY TRACT INFECTION 34 0.0080
537 MELANOCYTIC NAEVUS 35 0.0080
538 RASH PUSTULAR 58 0.0080
539 LABORATORY TEST ABNORMAL 235 0.0080
540 UMBILICAL HERNIA 37 0.0079
541 MOUTH HAEMORRHAGE 58 0.0079
542 SKIN LESION 216 0.0079
543 MUCOUS STOOLS 39 0.0079
544 BLOOD IRON DECREASED 93 0.0078
545 HEPATITIS B 47 0.0078
546 GASTROINTESTINAL INFLAMMATION 61 0.0078
547 SKIN LACERATION 84 0.0077
548 EYE HAEMORRHAGE 103 0.0077
549 CONJUNCTIVITIS 143 0.0077
550 PHYSICAL DISABILITY 34 0.0077
551 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 547 0.0077
552 ANAL FISTULA 41 0.0077
553 UTERINE LEIOMYOMA 56 0.0077
554 STRESS FRACTURE 41 0.0076
555 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1367 0.0076
556 MUSCULOSKELETAL DISCOMFORT 130 0.0075
557 GINGIVAL BLEEDING 103 0.0075
558 COVID-19 1321 0.0075
559 ROSACEA 35 0.0075
560 WEIGHT DECREASED 2092 0.0075
561 MENINGITIS 50 0.0075
562 FEELING HOT 458 0.0075
563 EAR DISORDER 34 0.0074
564 NAUSEA 5871 0.0074
565 SKIN DISORDER 247 0.0074
566 SPINAL OSTEOARTHRITIS 65 0.0074
567 CATARACT 440 0.0074
568 LIGAMENT RUPTURE 32 0.0072
569 ABDOMINAL DISTENSION 751 0.0072
570 STAPHYLOCOCCAL INFECTION 235 0.0071
571 PANCREATITIS 376 0.0071
572 PURULENT DISCHARGE 30 0.0070
573 STREPTOCOCCAL INFECTION 39 0.0070
574 ACCIDENT 83 0.0069
575 BLOOD CHOLESTEROL ABNORMAL 32 0.0069
576 HOSPITALISATION 1063 0.0069
577 GASTROINTESTINAL PAIN 76 0.0069
578 VITAMIN D DECREASED 59 0.0069
579 PHOTOPHOBIA 127 0.0067
580 PHARYNGITIS STREPTOCOCCAL 73 0.0067
581 FLANK PAIN 63 0.0067
582 HYPOCALCAEMIA 127 0.0067
583 CYST 83 0.0067
584 BLOOD TEST ABNORMAL 93 0.0066
585 COLON CANCER 98 0.0066
586 INGUINAL HERNIA 40 0.0066
587 IMMUNOSUPPRESSION 58 0.0066
588 LUMBAR VERTEBRAL FRACTURE 30 0.0065
589 TREATMENT NONCOMPLIANCE 358 0.0065
590 MUSCULOSKELETAL CHEST PAIN 101 0.0065
591 DYSPHORIA 33 0.0065
592 MOVEMENT DISORDER 209 0.0065
593 PRODUCT QUALITY ISSUE 883 0.0065
594 FLUID RETENTION 330 0.0065
595 ARTHROPOD BITE 48 0.0065
596 DIABETES MELLITUS 492 0.0064
597 GASTRITIS 169 0.0064
598 DIZZINESS 3198 0.0064
599 HYPOKINESIA 92 0.0063
600 PHARYNGEAL OEDEMA 97 0.0063
601 TENDON RUPTURE 76 0.0061
602 GENERALISED ERYTHEMA 35 0.0061
603 LEUKAEMIA 58 0.0061
604 FULL BLOOD COUNT ABNORMAL 65 0.0061
605 SQUAMOUS CELL CARCINOMA OF SKIN 37 0.0061
606 BLOOD PRESSURE DIASTOLIC DECREASED 45 0.0061
607 LIVER FUNCTION TEST ABNORMAL 177 0.0061
608 BODY HEIGHT DECREASED 65 0.0061
609 GENERALISED OEDEMA 75 0.0061
610 PELVIC PAIN 110 0.0060
611 SKIN PLAQUE 51 0.0060
612 DEVICE RELATED INFECTION 93 0.0060
613 CHOLECYSTECTOMY 69 0.0060
614 QUALITY OF LIFE DECREASED 81 0.0060
615 DYSSTASIA 175 0.0060
616 FOETAL EXPOSURE DURING PREGNANCY 484 0.0059
617 CATARACT OPERATION 35 0.0059
618 POOR QUALITY DRUG ADMINISTERED 38 0.0059
619 ECCHYMOSIS 40 0.0058
620 HIATUS HERNIA 75 0.0058
621 BRAIN NEOPLASM 53 0.0058
622 DEVICE OCCLUSION 81 0.0057
623 HUNGER 80 0.0057
624 BREAST CANCER STAGE I 53 0.0057
625 OVARIAN CYST 57 0.0057
626 MENISCUS INJURY 35 0.0057
627 DERMATITIS 118 0.0056
628 LIQUID PRODUCT PHYSICAL ISSUE 41 0.0056
629 MEDICAL DEVICE COMPLICATION 41 0.0055
630 TOOTH DISORDER 123 0.0055
631 IRON DEFICIENCY ANAEMIA 51 0.0055
632 MASS 77 0.0055
633 FALL 1833 0.0055
634 SCOLIOSIS 34 0.0055
635 ATELECTASIS 53 0.0055
636 SARS-COV-2 TEST POSITIVE 72 0.0054
637 COLITIS 206 0.0054
638 OVARIAN CANCER 50 0.0054
639 APHTHOUS ULCER 42 0.0054
640 FOOD POISONING 29 0.0054
641 UTERINE CANCER 43 0.0054
642 FUNGAL INFECTION 178 0.0053
643 ABNORMAL LOSS OF WEIGHT 36 0.0053
644 LIGAMENT SPRAIN 52 0.0053
645 LOSS OF CONSCIOUSNESS 673 0.0052
646 GROIN PAIN 46 0.0052
647 GASTRIC ULCER HAEMORRHAGE 29 0.0052
648 LUNG NEOPLASM MALIGNANT 215 0.0052
649 PULMONARY THROMBOSIS 57 0.0052
650 THERAPY CESSATION 268 0.0052
651 UPPER LIMB FRACTURE 104 0.0052
652 DRUG RESISTANCE 134 0.0052
653 ANXIETY 1483 0.0052
654 DEAFNESS 136 0.0052
655 HYPOKALAEMIA 239 0.0052
656 GENERAL PHYSICAL CONDITION ABNORMAL 35 0.0052
657 SPINAL COMPRESSION FRACTURE 42 0.0051
658 INTERVERTEBRAL DISC DEGENERATION 47 0.0051
659 SEPTIC SHOCK 220 0.0051
660 BLOOD PRESSURE FLUCTUATION 121 0.0050
661 VITAMIN D DEFICIENCY 49 0.0050
662 DEFAECATION URGENCY 35 0.0050
663 RHINORRHOEA 322 0.0050
664 BREAST CANCER 463 0.0050
665 RIB FRACTURE 102 0.0050
666 BREAST MASS 33 0.0049
667 TOOTH EXTRACTION 61 0.0049
668 SEPSIS 543 0.0049
669 PIGMENTATION DISORDER 30 0.0049
670 CARDIOVASCULAR DISORDER 123 0.0048
671 POST PROCEDURAL COMPLICATION 93 0.0048
672 HIDRADENITIS 44 0.0048
673 DIFFUSE LARGE B-CELL LYMPHOMA 37 0.0048
674 SECRETION DISCHARGE 60 0.0048
675 SCAR 82 0.0048
676 WRIST FRACTURE 56 0.0047
677 CARDIAC OPERATION 40 0.0046
678 TACHYCARDIA 412 0.0046
679 PRODUCT STORAGE ERROR 405 0.0046
680 HYPERAESTHESIA 38 0.0046
681 FEMUR FRACTURE 142 0.0046
682 POLYP 30 0.0046
683 PNEUMOTHORAX 72 0.0045
684 DRUG LEVEL DECREASED 46 0.0045
685 GASTROINTESTINAL CARCINOMA 41 0.0045
686 PRODUCT PRESCRIBING ERROR 107 0.0045
687 PRODUCT ADMINISTRATION ERROR 90 0.0044
688 LEUKOPENIA 221 0.0044
689 LIMB INJURY 120 0.0044
690 DUODENAL ULCER 31 0.0044
691 ESCHERICHIA INFECTION 36 0.0044
692 PLATELET COUNT INCREASED 57 0.0044
693 PROTEINURIA 83 0.0044
694 EYE DISORDER 143 0.0043
695 BONE DISORDER 79 0.0043
696 NERVE COMPRESSION 40 0.0043
697 CYTOMEGALOVIRUS INFECTION 72 0.0043
698 OROPHARYNGEAL PAIN 401 0.0043
699 ORAL PAIN 96 0.0043
700 BLOOD DISORDER 34 0.0042
701 ANAPHYLACTIC SHOCK 109 0.0042
702 GASTRIC ULCER 80 0.0042
703 PNEUMONITIS 114 0.0042
704 FORMICATION 29 0.0042
705 EMPHYSEMA 42 0.0042
706 HAEMORRHOIDS 81 0.0041
707 HYDRONEPHROSIS 31 0.0041
708 BLOOD PRESSURE INCREASED 633 0.0041
709 BLOOD URINE PRESENT 78 0.0041
710 SYNCOPE 409 0.0041
711 AFFECTIVE DISORDER 32 0.0041
712 INJECTION SITE HAEMORRHAGE 325 0.0041
713 GALLBLADDER DISORDER 72 0.0040
714 PANCREATIC CARCINOMA 116 0.0040
715 NASAL CONGESTION 234 0.0040
716 ERYTHEMA 815 0.0040
717 CRYING 144 0.0040
718 TENDON PAIN 30 0.0040
719 POOR VENOUS ACCESS 41 0.0040
720 OPTIC NEURITIS 36 0.0040
721 INCORRECT PRODUCT ADMINISTRATION DURATION 85 0.0039
722 FISTULA 44 0.0039
723 TOOTH FRACTURE 43 0.0039
724 PRODUCTIVE COUGH 186 0.0039
725 PRURITUS GENERALISED 84 0.0039
726 APHONIA 54 0.0039
727 PLEURAL EFFUSION 235 0.0039
728 MUSCLE STRAIN 33 0.0038
729 ATRIAL FIBRILLATION 367 0.0038
730 COUGH 1054 0.0038
731 INFLUENZA LIKE ILLNESS 309 0.0038
732 TRANSAMINASES INCREASED 83 0.0037
733 DRY EYE 185 0.0037
734 SINUS CONGESTION 50 0.0037
735 LYMPHADENOPATHY 129 0.0036
736 SPINAL FRACTURE 73 0.0036
737 DEEP VEIN THROMBOSIS 236 0.0036
738 POLYNEUROPATHY 43 0.0036
739 HEPATOMEGALY 35 0.0036
740 FACIAL PARALYSIS 30 0.0035
741 PHOTOSENSITIVITY REACTION 58 0.0035
742 EAR DISCOMFORT 36 0.0035
743 NEURALGIA 85 0.0035
744 CHOLELITHIASIS 114 0.0035
745 BURNING SENSATION 243 0.0035
746 SWOLLEN TONGUE 108 0.0035
747 POST PROCEDURAL HAEMORRHAGE 40 0.0034
748 DENTAL CARIES 38 0.0034
749 OSTEOPENIA 52 0.0034
750 OCULAR HYPERAEMIA 162 0.0034
751 PROCEDURAL PAIN 94 0.0034
752 ASPIRATION 37 0.0034
753 BACTERAEMIA 40 0.0034
754 SWELLING FACE 219 0.0034
755 HAEMATOMA 87 0.0034
756 INJECTION SITE WARMTH 69 0.0034
757 SCAB 38 0.0033
758 LOCAL SWELLING 58 0.0033
759 RENAL PAIN 35 0.0033
760 SLEEP APNOEA SYNDROME 63 0.0033
761 THROMBOSIS 262 0.0033
762 COMPLICATION ASSOCIATED WITH DEVICE 47 0.0032
763 DYSPHONIA 189 0.0032
764 HEPATITIS C 39 0.0032
765 ILLNESS 331 0.0032
766 FEELING JITTERY 61 0.0032
767 VERTIGO 194 0.0032
768 SINUS DISORDER 63 0.0032
769 HAEMORRHAGE 322 0.0031
770 DEMENTIA 86 0.0031
771 RED BLOOD CELL COUNT DECREASED 87 0.0030
772 SCRATCH 32 0.0030
773 BLOOD CREATININE INCREASED 196 0.0030
774 MOTOR DYSFUNCTION 30 0.0029
775 THROAT TIGHTNESS 79 0.0029
776 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 152 0.0029
777 EATING DISORDER 62 0.0029
778 GOUT 52 0.0029
779 HIP FRACTURE 92 0.0029
780 SKIN DISCOLOURATION 130 0.0028
781 GASTRIC CANCER 71 0.0028
782 INJECTION SITE BRUISING 223 0.0028
783 PARALYSIS 40 0.0028
784 HYPERTENSIVE CRISIS 31 0.0028
785 CHOLECYSTITIS 33 0.0028
786 ARRHYTHMIA 130 0.0027
787 HEART RATE INCREASED 270 0.0027
788 SEASONAL ALLERGY 38 0.0027
789 MUSCLE ATROPHY 34 0.0027
790 PAIN IN JAW 76 0.0027
791 INTESTINAL PERFORATION 30 0.0027
792 THERAPEUTIC RESPONSE SHORTENED 88 0.0027
793 INJECTION SITE DISCOLOURATION 33 0.0026
794 ABASIA 65 0.0026
795 DISEASE RECURRENCE 125 0.0026
796 CHILLS 308 0.0026
797 INJECTION SITE HAEMATOMA 38 0.0026
798 MYOCARDIAL INFARCTION 456 0.0026
799 WHITE BLOOD CELL COUNT DECREASED 283 0.0026
800 PERITONITIS 54 0.0026
801 RENAL DISORDER 121 0.0026
802 ANGINA PECTORIS 74 0.0026
803 BONE DENSITY DECREASED 80 0.0026
804 INTESTINAL OBSTRUCTION 96 0.0025
805 MYALGIA 428 0.0025
806 HEART RATE DECREASED 88 0.0025
807 RASH MACULO-PAPULAR 55 0.0025
808 FEEDING DISORDER 50 0.0025
809 DEVICE USE ISSUE 43 0.0025
810 CARDIOMEGALY 30 0.0024
811 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 133 0.0024
812 DYSURIA 89 0.0024
813 MOOD SWINGS 77 0.0024
814 BLINDNESS UNILATERAL 34 0.0024
815 ACUTE RESPIRATORY DISTRESS SYNDROME 42 0.0024
816 THINKING ABNORMAL 44 0.0024
817 POOR QUALITY SLEEP 50 0.0023
818 PALPITATIONS 271 0.0023
819 SENSORY DISTURBANCE 37 0.0023
820 LETHARGY 132 0.0023
821 ECZEMA 119 0.0023
822 INJECTION SITE MASS 84 0.0023
823 CARDIAC DISORDER 212 0.0023
824 PULMONARY EMBOLISM 215 0.0023
825 ABORTION SPONTANEOUS 90 0.0022
826 SNEEZING 50 0.0022
827 FEELING COLD 62 0.0022
828 INCORRECT DOSE ADMINISTERED 508 0.0022
829 HAEMOGLOBIN DECREASED 228 0.0022
830 BONE PAIN 130 0.0022
831 PULMONARY OEDEMA 99 0.0022
832 ACUTE MYOCARDIAL INFARCTION 65 0.0022
833 PRODUCT DISPENSING ERROR 48 0.0022
834 TINNITUS 101 0.0022
835 INCORRECT DOSE ADMINISTERED BY DEVICE 57 0.0022
836 CEREBRAL INFARCTION 53 0.0022
837 THERAPY INTERRUPTED 155 0.0022
838 BLOOD PRESSURE ABNORMAL 43 0.0022
839 RASH GENERALISED 56 0.0022
840 MUCOSAL INFLAMMATION 56 0.0021
841 MULTIPLE FRACTURES 35 0.0021
842 PRODUCT AVAILABILITY ISSUE 48 0.0021
843 HEAD DISCOMFORT 37 0.0021
844 WRONG TECHNIQUE IN DRUG USAGE PROCESS 75 0.0021
845 EYE PAIN 116 0.0021
846 THERAPY PARTIAL RESPONDER 32 0.0020
847 THROMBOCYTOPENIA 229 0.0020
848 INJECTION SITE PRURITUS 137 0.0020
849 SPEECH DISORDER 107 0.0020
850 RENAL IMPAIRMENT 171 0.0020
851 PERICARDIAL EFFUSION 47 0.0020
852 INSURANCE ISSUE 31 0.0020
853 SOMNOLENCE 408 0.0020
854 INJECTION SITE ERYTHEMA 251 0.0020
855 ANGIOEDEMA 89 0.0020
856 CEREBROVASCULAR ACCIDENT 337 0.0020
857 TOOTHACHE 36 0.0020
858 DRUG PRESCRIBING ERROR 38 0.0020
859 PRODUCT COMPLAINT 50 0.0020
860 ACTIVITIES OF DAILY LIVING IMPAIRED 39 0.0020
861 PROSTATE CANCER 158 0.0020
862 ANAEMIA 374 0.0020
863 EOSINOPHILIA 34 0.0019
864 HAEMATEMESIS 49 0.0019
865 TRANSIENT ISCHAEMIC ATTACK 65 0.0019
866 OSTEONECROSIS 63 0.0019
867 DEPRESSED MOOD 101 0.0019
868 PAIN OF SKIN 51 0.0019
869 CARDIAC FAILURE 152 0.0019
870 NEUROPATHY PERIPHERAL 179 0.0019
871 UNEVALUABLE EVENT 142 0.0019
872 TREMOR 311 0.0019
873 HYPOTENSION 375 0.0019
874 BLOOD TRIGLYCERIDES INCREASED 33 0.0019
875 POLLAKIURIA 77 0.0018
876 OVERDOSE 395 0.0018
877 INTENTIONAL PRODUCT MISUSE 160 0.0018
878 MIDDLE INSOMNIA 34 0.0018
879 RASH ERYTHEMATOUS 87 0.0018
880 OXYGEN SATURATION DECREASED 102 0.0018
881 EYE SWELLING 67 0.0018
882 NERVOUS SYSTEM DISORDER 56 0.0018
883 FEELING ABNORMAL 425 0.0018
884 HEAD INJURY 56 0.0018
885 HEPATIC FUNCTION ABNORMAL 66 0.0018
886 INJECTION SITE PAIN 538 0.0018
887 BLOOD POTASSIUM DECREASED 52 0.0017
888 HAEMOPTYSIS 48 0.0017
889 MULTIPLE SCLEROSIS 81 0.0017
890 THROAT IRRITATION 76 0.0017
891 HYPOTHYROIDISM 54 0.0017
892 MELAENA 37 0.0017
893 HAEMATOCRIT DECREASED 33 0.0017
894 EPISTAXIS 124 0.0017
895 MENTAL DISORDER 72 0.0017
896 PANCREATITIS ACUTE 37 0.0016
897 DIABETES MELLITUS INADEQUATE CONTROL 29 0.0016
898 HEART RATE IRREGULAR 37 0.0016
899 SKIN FISSURES 32 0.0016
900 EMOTIONAL DISORDER 50 0.0016
901 CEREBRAL HAEMORRHAGE 58 0.0016
902 PLASMA CELL MYELOMA 63 0.0016
903 HYPERHIDROSIS 206 0.0016
904 PRODUCT PHYSICAL ISSUE 32 0.0016
905 CHEST DISCOMFORT 162 0.0016
906 HYPOACUSIS 68 0.0016
907 INJECTION SITE RASH 48 0.0016
908 NERVOUSNESS 81 0.0015
909 EYE IRRITATION 89 0.0015
910 BLOOD PRESSURE DECREASED 101 0.0015
911 PANCYTOPENIA 84 0.0015
912 HYPERSOMNIA 43 0.0015
913 DRUG ADMINISTRATION ERROR 46 0.0015
914 RENAL CANCER 71 0.0015
915 PRESYNCOPE 36 0.0015
916 URINARY INCONTINENCE 43 0.0014
917 SKIN EXFOLIATION 122 0.0014
918 URINARY RETENTION 48 0.0014
919 RASH PAPULAR 32 0.0014
920 RENAL FAILURE 187 0.0014
921 DYSPNOEA EXERTIONAL 52 0.0014
922 PREMATURE BABY 41 0.0014
923 PLATELET COUNT DECREASED 145 0.0014
924 FAECES DISCOLOURED 29 0.0013
925 INTENTIONAL DOSE OMISSION 38 0.0013
926 HEPATIC CANCER 32 0.0013
927 FLUSHING 135 0.0013
928 DIPLOPIA 34 0.0013
929 GAMMA-GLUTAMYLTRANSFERASE INCREASED 29 0.0013
930 ACNE 99 0.0013
931 SEIZURE 150 0.0013
932 INJECTION SITE SWELLING 99 0.0013
933 BLINDNESS 52 0.0013
934 FEAR 34 0.0013
935 INJECTION SITE URTICARIA 31 0.0013
936 BALANCE DISORDER 109 0.0013
937 HAEMATURIA 43 0.0013
938 PALLOR 34 0.0012
939 DEHYDRATION 166 0.0012
940 CORONARY ARTERY DISEASE 37 0.0012
941 FLATULENCE 69 0.0012
942 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 245 0.0012
943 DYSPHAGIA 113 0.0012
944 THERAPEUTIC RESPONSE UNEXPECTED 53 0.0012
945 VISUAL ACUITY REDUCED 39 0.0012
946 VISION BLURRED 161 0.0012
947 DEATH 995 0.0012
948 SUICIDAL IDEATION 105 0.0011
949 LACRIMATION INCREASED 34 0.0011
950 GASTROINTESTINAL HAEMORRHAGE 94 0.0011
951 RESPIRATORY FAILURE 81 0.0011
952 DRUG DEPENDENCE 178 0.0011
953 DRY SKIN 147 0.0011
954 CONSTIPATION 240 0.0011
955 NO ADVERSE EVENT 199 0.0011
956 ACUTE KIDNEY INJURY 166 0.0011
957 EYE PRURITUS 36 0.0011
958 ACCIDENTAL OVERDOSE 37 0.0010
959 CARDIAC FAILURE CONGESTIVE 80 0.0010
960 NEUTROPHIL COUNT DECREASED 40 0.0010
961 COGNITIVE DISORDER 45 0.0010
962 HEPATIC FAILURE 29 0.0010
963 ANGER 31 0.0009
964 BLOOD GLUCOSE INCREASED 168 0.0009
965 DISEASE PROGRESSION 105 0.0009
966 VAGINAL HAEMORRHAGE 38 0.0009
967 HOT FLUSH 64 0.0008
968 COMA 40 0.0008
969 HALLUCINATION 63 0.0008
970 PANIC ATTACK 30 0.0008
971 NEUTROPENIA 111 0.0008
972 DRUG INTERACTION 124 0.0008
973 BLADDER CANCER 46 0.0008
974 DYSGEUSIA 55 0.0007
975 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 33 0.0007
976 SKIN IRRITATION 32 0.0007
977 IRRITABILITY 38 0.0006
978 CONVULSION 33 0.0006
979 AGITATION 42 0.0006
980 CARDIAC ARREST 47 0.0006
981 BRADYCARDIA 29 0.0005
982 HYPONATRAEMIA 30 0.0005
983 TOXICITY TO VARIOUS AGENTS 89 0.0005
984 SKIN BURNING SENSATION 34 0.0005
985 DRUG DOSE OMISSION BY DEVICE 37 0.0005
986 EMOTIONAL DISTRESS 57 0.0005